Bingling Dai

1.3k total citations
60 papers, 972 citations indexed

About

Bingling Dai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bingling Dai has authored 60 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Bingling Dai's work include Angiogenesis and VEGF in Cancer (10 papers), Cancer Mechanisms and Therapy (8 papers) and Metal-Organic Frameworks: Synthesis and Applications (6 papers). Bingling Dai is often cited by papers focused on Angiogenesis and VEGF in Cancer (10 papers), Cancer Mechanisms and Therapy (8 papers) and Metal-Organic Frameworks: Synthesis and Applications (6 papers). Bingling Dai collaborates with scholars based in China, United States and Australia. Bingling Dai's co-authors include Yanmin Zhang, Yingzhuan Zhan, Dongdong Zhang, Tianfeng Yang, Weina Ma, Qi Su, Langchong He, Mengying Fan, Nan Wang and Rui Liu and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Bingling Dai

57 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingling Dai China 19 544 199 135 128 88 60 972
Hong Xiang Zuo China 21 582 1.1× 214 1.1× 157 1.2× 196 1.5× 102 1.2× 37 1.3k
Guobing� Li China 23 805 1.5× 205 1.0× 71 0.5× 121 0.9× 60 0.7× 47 1.4k
Yuxin Li China 22 643 1.2× 163 0.8× 93 0.7× 151 1.2× 46 0.5× 68 1.2k
Myeong Jin Nam South Korea 23 819 1.5× 189 0.9× 156 1.2× 199 1.6× 141 1.6× 56 1.5k
Yingzhuan Zhan China 18 487 0.9× 134 0.7× 105 0.8× 97 0.8× 56 0.6× 39 1.0k
Yuanzhi Lao China 18 716 1.3× 217 1.1× 178 1.3× 120 0.9× 40 0.5× 30 1.1k
Joanna Jakubowicz-Gil Poland 21 564 1.0× 105 0.5× 93 0.7× 134 1.0× 83 0.9× 55 1.1k
Tianxin Yang China 21 671 1.2× 120 0.6× 62 0.5× 170 1.3× 62 0.7× 30 1.2k

Countries citing papers authored by Bingling Dai

Since Specialization
Citations

This map shows the geographic impact of Bingling Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingling Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingling Dai more than expected).

Fields of papers citing papers by Bingling Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingling Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingling Dai. The network helps show where Bingling Dai may publish in the future.

Co-authorship network of co-authors of Bingling Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Bingling Dai. A scholar is included among the top collaborators of Bingling Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingling Dai. Bingling Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Henglin, Yanan Zhao, Haitao Tu, et al.. (2025). MeP Induces Metabolic Disorder and Liver Damage at Human-Relevant Exposure Levels: Role of the Gut Microbiota. Environment & Health. 3(11). 1393–1405.
2.
Wang, Xuemei, Yuhong Li, Yanbin Chen, et al.. (2024). Yangzheng mixture reversed EMT against hepatocellular carcinoma metastasis via NF-κB/NLRP3/β-catenin pathway. Toxicon. 250. 108090–108090. 1 indexed citations
3.
Dai, Bingling, Hanbing Cao, Yu Hu, et al.. (2023). Role of NLRP3 inflammasome activation in HCC cell progression. Heliyon. 9(9). e19542–e19542. 4 indexed citations
4.
Zhang, Yusheng, Yuming Su, Xiaolin Fan, et al.. (2023). Multicolor Patterning Inside a Metal‐Organic Framework. Advanced Optical Materials. 11(19). 4 indexed citations
5.
Wu, Shaobo, Wen Zhang, Xinyu Ma, et al.. (2023). Investigation of GPR143 as a promising novel marker for the progression of skin cutaneous melanoma through bioinformatic analyses and cell experiments. APOPTOSIS. 29(3-4). 372–392. 6 indexed citations
6.
Yang, Tianfeng, Runze Yu, Cheng Cheng, et al.. (2023). Cantharidin induces apoptosis of human triple negative breast cancer cells through mir-607-mediated downregulation of EGFR. Journal of Translational Medicine. 21(1). 597–597. 23 indexed citations
7.
Dai, Bingling, Hanbing Cao, Yu Hu, et al.. (2023). Identification and analysis of anti‐tumor effective substances in Yangzheng Mixture. Biomedical Chromatography. 37(9). e5692–e5692. 2 indexed citations
8.
Ma, Weina, Man Zhu, Bo Wang, et al.. (2022). Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type‐B receptor 4. Molecular Oncology. 16(14). 2747–2765. 5 indexed citations
9.
Dai, Bingling, Mengying Fan, Hanbing Cao, et al.. (2022). Shuanghua decoction exerts anticancer activity by activating NLRP3 inflammasome via ROS and inhibiting NF-κB signaling in hepatocellular carcinoma cells. Phytomedicine. 103. 154249–154249. 18 indexed citations
10.
Wu, Shaobo, et al.. (2021). The role of NLRP3 in the prognosis and immune infiltrates of skin cutaneous melanoma (SKCM). Translational Cancer Research. 10(4). 1692–1702. 9 indexed citations
11.
Zhu, Man, Xianpeng Shi, Qi Su, et al.. (2020). Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner. Pharmacological Research. 158. 104868–104868. 54 indexed citations
12.
Dai, Bingling, Yujiao Ma, Yingzhuan Zhan, et al.. (2017). Dihydroberberine exhibits synergistic effects with sunitinib on NSCLC NCI‐H460 cells by repressing MAP kinase pathways and inflammatory mediators. Journal of Cellular and Molecular Medicine. 21(10). 2573–2585. 7 indexed citations
13.
Wang, Jinfeng, Lin Zhang, Xiaoyan Pan, et al.. (2017). Discovery of multi-target receptor tyrosine kinase inhibitors as novel anti-angiogenesis agents. Scientific Reports. 7(1). 45145–45145. 20 indexed citations
14.
Dai, Bingling, Wenjie Wang, Yujiao Ma, Rui Liu, & Yanmin Zhang. (2016). A taspine derivative supresses Caco-2 cell growth by competitively targeting EphrinB2 and regulating its pathway. Oncology Reports. 36(3). 1526–1534. 4 indexed citations
15.
Liu, Rui, Wenjie Wang, Bingling Dai, Yanping Liu, & Yanmin Zhang. (2015). Taspine derivative TAS9 regulates cell growth and metastasis of human hepatocellular carcinoma. Molecular Medicine Reports. 12(5). 7735–7741.
16.
Dai, Bingling, Yingzhuan Zhan, Junpeng Qi, & Yanmin Zhang. (2014). Eupolyphaga sinensis Walker inhibits human chronic myeloid leukemia cell K562 growth by inducing G2–M phase cell cycle arrest and targeting EGFR signaling pathway and in S180 tumor-bearing mice. Environmental Toxicology and Pharmacology. 37(3). 1177–1185. 15 indexed citations
17.
Dai, Bingling, Yanmin Zhang, Yingzhuan Zhan, et al.. (2014). A novel tissue model for angiogenesis: evaluation of inhibitors or promoters in tissue level. Scientific Reports. 4(1). 3693–3693. 7 indexed citations
18.
Zheng, Lei, Xu He, Weina Ma, et al.. (2012). Ta1722, an anti-angiogenesis inhibitor targeted on VEGFR-2 against human hepatoma. Biomedicine & Pharmacotherapy. 66(7). 499–505. 8 indexed citations
19.
Zhang, Yanmin, Lei Zheng, Jie Zhang, et al.. (2011). Antitumor Activity of Taspine by Modulating the EGFR Signaling Pathway of Erk1/2 and AktIn VitroandIn Vivo. Planta Medica. 77(16). 1774–1781. 22 indexed citations
20.
Zhang, Yanmin, Qiao Jiang, Nan Wang, et al.. (2010). Effects of taspine on proliferation and apoptosis by regulating caspase‐3 expression and the ratio of Bax/Bcl‐2 in A431 cells. Phytotherapy Research. 25(3). 357–364. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Xiang Zuo Breakdown of academic impact, for papers by Guobing� Li Breakdown of academic impact, for papers by Yuxin Li Breakdown of academic impact, for papers by Myeong Jin Nam Breakdown of academic impact, for papers by Yingzhuan Zhan Breakdown of academic impact, for papers by Yuanzhi Lao Breakdown of academic impact, for papers by Joanna Jakubowicz-Gil Breakdown of academic impact, for papers by Tianxin Yang
Rankless by CCL
2026